References
Daly, M. B., Axilbund, J. E., Buys, S., Crawford, B., Farrell, C. D., Friedman, S., … Weitzel, J. N. (2013). Genetic/familial high risk assessment: Breast and ovarian [v.1.2013].
Journal of the National Comprehensive Cancer Network. Retrieved from
http://www.jnccn.org/contents/8/5/562.long http://www.jnccn.org/contents/8/5/562.long
Ewald, I. P., Ribeiro, P. L. I., Palmero, E. I., Cossio, S. L., Giugliani, R., & Ashton-Prolla, P. (2009). Genomic rearrangements in BRCA1 and BRCA2: A literature review. Genetics and Molecular Biology, 32, 437-446.
Hansen, T. O., Jønson, L., Albrechtsen, A., Andersen, M., Ejlertsen, B., & Nielsen, F. (2009). Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families. Breast Cancer Research and Treatment, 115, 315-323. doi:10.1007/s10549-008-0088-0
Hartman, A. R., Kaldate, R. R., Sailer, L. M., Painter, L., Grier, C. E., Endsley, R. R., … Sandbach, J. F. (2012). Prevalence of BRCA mutations in an unselected population of triple-negative breast cancer. Cancer, 118, 2787-2795. doi:10.1002/cncr.26576
Judkins, T., Rosenthal, E., Arnell, C., Burbidge, L. A., Geary, W., Barrus, T., … Roa, B. B. (2012). Clinical significance of large rearrangements in BRCA1 and BRCA2.Cancer, 118, 5210-5216. doi:10.1002/cncr.27556
Kwon, J. S., Gutierrez-Barrera, A. M., Young, D., Sun, C. C., Daniels, M. S., Lu, K. H., & Arun, B. (2010). Expanding the criteria for BRCA mutation testing in breast cancer survivors. Journal of Clinical Oncology, 28, 4214-4220. doi:10.1200/jco.2010.28.0719
Lindor, N. M., McMaster, M. L., Lindor, C. J., & Greene, M. H. (2008). Concise handbook of familial cancer susceptibility syndromes (2nd ed.). Journal of the National Cancer Institute. Monographs, 38, 1-93. doi:10.1093/jncimonographs/lgn001
Machado, P. M., Brandão, R. D., Cavaco, B. M., Eugénio, J., Bento, S., Nave, M., … Vaz, F. (2007). Screening for a BRCA2 rearrangement in high-risk breast/ovarian cancer families: Evidence for a founder effect and analysis of the associated phenotypes. Journal of Clinical Oncology, 25, 2027-2034. doi:10.1200/jco.2006.06.9443
Mahon, S. M. (2012). Complexities of genetic care: Implications for advanced practice nurses. Journal for Nurse Practitioners, 8(8), e23-e27. doi:10.1016/j.nurpra.2012.04.020
Palma, M. D., Domchek, S. M., Stopfer, J., Erlichman, J., Siegfried, J. D., Tigges-Cardwell, J., … Nathanson, K. L. (2008). The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families. Cancer Research, 68, 7006-7014. doi:10.1158/0008-5472.can-08-0599
Pyeritz, R. E. (2011). The coming explosion in genetic testing—Is there a duty to recontact? New England Journal of Medicine, 365, 1367-1369. doi:10.1056/NEJMp1107564
Qureshi, N., Carroll, J. C., Wilson, B., Santaguida, P., Allanson, J., Brouwers, M., & Raina, P. (2009). The current state of cancer family history collection tools in primary care: A systematic review. Genetics in Medicine, 11, 495-506.
Rodríguez, M., Torres, A., Borràs, J., Salvat, M., & Gumà, J. (2010). Large genomic rearrangements in mutation-negative BRCA families: A population-based study. Clinical Genetics, 78, 405-407.
Rubinstein, W. S. (2008). Roles and responsibilities of a medical geneticist. Familial Cancer, 7, 5-14. doi:10.1007/s10689-007-9148-6
Shannon, K. M., Rodgers, L. H., Chan-Smutko, G., Patel, D., Gabree, M., & Ryan, P. D. (2011). Which individuals undergoing BRACAnalysis® need BART testing? Cancer Genetics, 204, 416-422.
Sluiter, M., & Rensburg, E. (2011). Large genomic rearrangements of the BRCA1 and BRCA2 genes: Review of the literature and report of a novel BRCA1 mutation. Breast Cancer Research and Treatment, 125, 325-349.
Stadler, Z., Saloustros, E., Hansen, N. L., Schluger, A., Kauff, N., Offit, K., & Robson, M. (2010). Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families. Breast Cancer Research and Treatment, 123, 581-585. doi:10.1007/s10549-010-0818-y
Valle, J., Feliubadaló, L., Nadal, M., Teulé, A., Miró, R., Cuesta, R., … Lázaro, C. (2010). Identification and comprehensive characterization of large genomic rearrangements in the BRCA1 and BRCA2 genes. Breast Cancer Research and Treatment, 122, 733-743. doi:10.1007/s10549-009-0613-9
Weitzel, J. N., Clague, J., Martir-Negron, A., Ogaz, R., Herzog, J., Ricker, C., … Larson, G. P. (2012). Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the Southwestern United States: A report from the Clinical Cancer Genetics Community Research Network. Journal of Clinical Oncology, 31, 210-216. doi:10.1200/jco.2011.41.0027